Process for synthesizing prasugrel
A synthesis process and salt addition technology, applied in the direction of organic chemistry, can solve the problems of compound V being uneconomical, unsuitable for large-scale industrial production, and high losses, so as to improve synthesis efficiency, reduce purity dependence, and save time. Effect
Inactive Publication Date: 2010-08-25
SHANDONG XINHUA PHARMA CO LTD
View PDF5 Cites 4 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Exist time-consuming and laborious in these preparation processes, be unfavorable for the deficiency of industrialization: (1) when synthesizing this key intermediate (IV), generally require the compound V purity of preparation to be higher, need column chromatographic separation during preparation time-consuming and laborious, not suitable for large-scale industrialization Production, if the temperature of preparing compound V by rectification is too high, it is uneconomical to easily polymerize and lose a large amount of compound V, and it is easy to fail; (2) after the key intermediate compound IV is prepared, it is generally time-consuming and laborious to separate by column chromatography, and the loss is relatively large many
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention provides a novel process for synthesizing prasugrel. In the process, a prasugrel intermediate addition salt having a ketone-enol tautomer structure is used for preparing the prasugrel, so that the process has the advantages of easy synthesis, easy storage and convenient preparation of prasugrel. Due to the use of the intermediate addition in the preparation of the prasugrel, the purity requirement on synthesis raw materials is lowered, the time-consuming and labor-consuming process of column chromatography separation of the intermediates is eliminated, the separation purification efficiency is improved, and the process is quite suitable for the industrialized production of the prasugrel.
Description
technical field The present invention relates to chemical synthesis, in particular to the preparation of platelet inhibitor prasugrel. Background technique Thienopyridines such as ticlopidine and clopidogrel have been used to treat thrombosis and related diseases. As a new generation of thienopyridine oral antiplatelet drugs, prasugrel has also been launched under the trade name Effient. The structural formula of prasugrel, such as III, is an adenosine diphosphate (ADP) receptor antagonist, which belongs to the prodrug, which itself does not have activity and is effectively converted into its active metabolite R-138727 in vivo; R- 138727 reduces the dependence on cytochrome P-450 enzymes, and rapidly, specifically, and irreversibly binds to the purine base receptors of platelet P2Y12, inhibiting ADP-regulated platelet activity and aggregation. Patent EP0542411 first disclosed tetrahydrothienopyridine derivatives including prasugrel, and later many patents related to the s...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): C07D495/04
Inventor 李进都孙科常森
Owner SHANDONG XINHUA PHARMA CO LTD
